Home › Therapeutic areas › Oncology › Atypical Teratoid/Rhabdoid Tumor
Atypical Teratoid/Rhabdoid Tumor (1 companies)
Companies with an active program in Atypical Teratoid/Rhabdoid Tumor.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| KZIA | Kazia Therapeutics | NeurologyOncology Rare | 1 | Phase 2 | $82.0M | 13 |
No companies match.